Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Chin-Wei Huang, Kanokwan Boonyapisit, Suryani Gunadharma, Josephine Casanova-Gutierrez, Liri Jin, Dinesh Nayak & Naoki Akamatsu. (2022) Optimal Use of Perampanel in Elderly Asian Patients with Epilepsy: Expert Opinion. Therapeutics and Clinical Risk Management 18, pages 825-832.
Read now
Read now
Stefano de Biase, Annacarmen Nilo, Andrea Bernardini, Gian Luigi Gigli, Mariarosaria Valente & Giovanni Merlino. (2019) Timing use of novel anti-epileptic drugs: is earlier better?. Expert Review of Neurotherapeutics 19:10, pages 945-954.
Read now
Read now
Alberto Verrotti, Giulia Iapadre, Giulia Di Donato, Ludovica Di Francesco, Luca Zagaroli, Sara Matricardi, Vincenzo Belcastro & Maria Laura Iezzi. (2019) Pharmacokinetic considerations for anti-epileptic drugs in children. Expert Opinion on Drug Metabolism & Toxicology 15:3, pages 199-211.
Read now
Read now
Stefano de Biase, Gian Luigi Gigli, Annacarmen Nilo, Giorgia Romano & Mariarosaria Valente. (2019) Pharmacokinetic and pharmacodynamic considerations for the clinical efficacy of perampanel in focal onset seizures. Expert Opinion on Drug Metabolism & Toxicology 15:2, pages 93-102.
Read now
Read now
Andreas Schulze-Bonhage. (2017) A 2017 review of pharmacotherapy for treating focal epilepsy: where are we now and how will treatment develop?. Expert Opinion on Pharmacotherapy 18:17, pages 1845-1853.
Read now
Read now
Andreas Schulze-Bonhage & Mandy Hintz. (2015) Perampanel in the management of partial-onset seizures: a review of safety, efficacy, and patient acceptability. Patient Preference and Adherence 9, pages 1143-1151.
Read now
Read now
Articles from other publishers (9)
Wang-Tso Lee, Derrick Wei Shih Chan, Sheffali Gulati, Surachai Likasitwattanakul, Byung Chan Lim, Akihisa Okumura, Benilda Sanchez-Gan, Yi Wang & Kam Tim Liu. (2024) Role of Perampanel in the Management of Pediatric Epilepsies in Asia: Expert Opinion. Pediatric Neurology 151, pages 5-16.
Crossref
Crossref
Chaofeng Zhu, Juan Li, Dazhu Wei, Luyan Wu, Yuying Zhang, Huapin Huang & Wanhui Lin. (2023) A nomogram to predict the treatment benefit of perampanel in drug-resistant epilepsy patients. Frontiers in Neurology 14.
Crossref
Crossref
Sara Meirinho, Márcio Rodrigues, Ana Fortuna, Amílcar Falcão & Gilberto Alves. (2022) Study of the metabolic stability profiles of perampanel, rufinamide and stiripentol and prediction of drug interactions using HepaRG cells as an in vitro human model. Toxicology in Vitro 82, pages 105389.
Crossref
Crossref
Ziad Hussein, Oneeb Majid, Peter Boyd, Jagadeesh Aluri, Leock Y Ngo & Larisa Reyderman. (2022) Intravenous Perampanel as an Interchangeable Alternative to Oral Perampanel: A Randomized, Crossover, Phase I Pharmacokinetic and Safety Study. Clinical Pharmacology in Drug Development 11:7, pages 878-888.
Crossref
Crossref
Bernhard J. Steinhoff, Elisabeth Hübers, Christoph Kurth & Uta Jürges (Kehl-Kork). (2019) Plasma concentration and clinical effects of perampanel—The Kork experience. Seizure 67, pages 18-22.
Crossref
Crossref
J.-J. Tsai, T. Wu, H. Leung, T. Desudchit, S. Tiamkao, K.-S. Lim & A. Dash. (2018) Perampanel, an AMPA receptor antagonist: From clinical research to practice in clinical settings. Acta Neurologica Scandinavica 137:4, pages 378-391.
Crossref
Crossref
F. K. Rider. (2017) Perampanel in the treatment of patients with epilepsy. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 117:9, pages 63.
Crossref
Crossref
M. Hintz, S. Nawratil & A. Schulze-Bonhage. (2016) Perampanel als Therapieoption bei EpilepsiepatientenPerampanel as a therapy option in patients with epilepsy. Der Nervenarzt 87:8, pages 870-878.
Crossref
Crossref
Francesca Bagnato & Janine Good. (2016) The Use of Antiepileptics in Migraine Prophylaxis. Headache: The Journal of Head and Face Pain 56:3, pages 603-615.
Crossref
Crossref